Anavasi Diagnostics COVID Test and Molecular Detector Get Emergency Use Authorization
The FDA issued an Emergency Use Authorization for Anavasi Diagnostics’ AscencioDx COVID-19 Test and The AscencioDx Molecular Detector.
Read MorePosted by Andy Lundin | Feb 13, 2023 | Covid 19 |
The FDA issued an Emergency Use Authorization for Anavasi Diagnostics’ AscencioDx COVID-19 Test and The AscencioDx Molecular Detector.
Read MorePosted by Andy Lundin | Aug 3, 2022 | Covid 19, Rapid Assays |
Researchers have developed a SARS-CoV-2 saliva assay and prototype device that combine speed and ease with high sensitivity.
Read MorePosted by Andy Lundin | Feb 7, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The detection system can be readily adapted for other pathogens with pandemic potential, including deadly variants of COVID and flu.
Read MorePosted by Andy Lundin | Jan 26, 2022 | Covid 19, POC Reagents & Test Kits |
Researchers have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests.
Read MorePosted by Andy Lundin | Jan 3, 2022 | Covid 19, Immunoassay Reagents & test Kits |
A high-quality assay that can be used in at-home tests for rapid COVID-19 screening may be just as reliable as the laboratory-based PCR molecular tests.
Read More